Suppr超能文献

查尔酮:药物化学中的一种优势结构。

Chalcone: A Privileged Structure in Medicinal Chemistry.

作者信息

Zhuang Chunlin, Zhang Wen, Sheng Chunquan, Zhang Wannian, Xing Chengguo, Miao Zhenyuan

机构信息

School of Pharmacy, Second Military Medical University , 325 Guohe Road, Shanghai 200433, China.

School of Pharmacy, Ningxia Medical University , 1160 Shengli Street, Yinchuan 750004, China.

出版信息

Chem Rev. 2017 Jun 28;117(12):7762-7810. doi: 10.1021/acs.chemrev.7b00020. Epub 2017 May 10.

Abstract

Privileged structures have been widely used as an effective template in medicinal chemistry for drug discovery. Chalcone is a common simple scaffold found in many naturally occurring compounds. Many chalcone derivatives have also been prepared due to their convenient synthesis. These natural products and synthetic compounds have shown numerous interesting biological activities with clinical potentials against various diseases. This review aims to highlight the recent evidence of chalcone as a privileged scaffold in medicinal chemistry. Multiple aspects of chalcone will be summarized herein, including the isolation of novel chalcone derivatives, the development of new synthetic methodologies, the evaluation of their biological properties, and the exploration of the mechanisms of action as well as target identification. This review is expected to be a comprehensive, authoritative, and critical review of the chalcone template to the chemistry community.

摘要

特权结构作为药物发现中药物化学的有效模板已被广泛应用。查尔酮是许多天然化合物中常见的简单骨架。由于其合成简便,许多查尔酮衍生物也已被制备出来。这些天然产物和合成化合物已显示出众多有趣的生物活性,具有针对各种疾病的临床潜力。本综述旨在突出查尔酮作为药物化学中特权骨架的最新证据。本文将总结查尔酮的多个方面,包括新型查尔酮衍生物的分离、新合成方法的开发、其生物学性质的评估以及作用机制的探索和靶点鉴定。本综述有望成为化学界对查尔酮模板的全面、权威且批判性的综述。

相似文献

1
Chalcone: A Privileged Structure in Medicinal Chemistry.
Chem Rev. 2017 Jun 28;117(12):7762-7810. doi: 10.1021/acs.chemrev.7b00020. Epub 2017 May 10.
2
Medicinal chemistry of vicinal diaryl scaffold: A mini review.
Eur J Med Chem. 2019 Jan 15;162:1-17. doi: 10.1016/j.ejmech.2018.10.054. Epub 2018 Oct 31.
3
2,4-Diketo esters: Crucial intermediates for drug discovery.
Bioorg Chem. 2020 Dec;105:104343. doi: 10.1016/j.bioorg.2020.104343. Epub 2020 Oct 8.
4
Significance of Chalcone Scaffolds in Medicinal Chemistry.
Top Curr Chem (Cham). 2024 Jun 27;382(3):22. doi: 10.1007/s41061-024-00468-7.
5
Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review.
Eur J Med Chem. 2020 May 1;193:112215. doi: 10.1016/j.ejmech.2020.112215. Epub 2020 Mar 9.
6
Targeting GABA receptors with chalcone derivative compounds, what is the evidence?
Expert Opin Ther Targets. 2023 Jul-Dec;27(12):1257-1269. doi: 10.1080/14728222.2023.2293752. Epub 2023 Dec 30.
7
Chalcone hybrids and their antimalarial activity.
Arch Pharm (Weinheim). 2020 Apr;353(4):e1900350. doi: 10.1002/ardp.201900350. Epub 2020 Jan 31.
8
Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.
Bioorg Chem. 2021 Mar;108:104681. doi: 10.1016/j.bioorg.2021.104681. Epub 2021 Jan 29.
9
Rearranged ergostane-type natural products: chemistry, biology, and medicinal aspects.
Org Biomol Chem. 2019 Feb 13;17(7):1624-1633. doi: 10.1039/c8ob02325e.
10
Flexibility in the bridge of chalcone derivatives is important for the inhibition of cellular growth.
Bioorg Med Chem Lett. 2023 Oct 15;95:129467. doi: 10.1016/j.bmcl.2023.129467. Epub 2023 Sep 4.

引用本文的文献

3
Design and Synthesis of Boronic Chalcones with Dual Anticancer and Anti-Inflammatory Activity.
Molecules. 2025 Jul 19;30(14):3032. doi: 10.3390/molecules30143032.
5
High-pressure activation for the solvent- and catalyst-free syntheses of heterocycles, pharmaceuticals and esters.
Beilstein J Org Chem. 2025 Jul 2;21:1374-1387. doi: 10.3762/bjoc.21.102. eCollection 2025.
6
Palladium-Catalyzed Selenylative Alkoxycarbonylation of Alkynes toward β-Selenated Cinnamic Acid Esters.
Org Lett. 2025 Jul 18;27(28):7714-7718. doi: 10.1021/acs.orglett.5c02491. Epub 2025 Jul 4.
7
Pharmacological potential of natural chalcones: a recent studies and future perspective.
Front Pharmacol. 2025 Jun 17;16:1570385. doi: 10.3389/fphar.2025.1570385. eCollection 2025.
10
Crystal structure and Hirshfeld-surface analysis of 1-(4-fluoro-phen-yl)-3,3-bis-(methyl-sulfan-yl)prop-2-en-1-one.
Acta Crystallogr E Crystallogr Commun. 2025 May 13;81(Pt 6):516-519. doi: 10.1107/S2056989025004189. eCollection 2025 Jun 1.

本文引用的文献

1
Chalcone-analogue fluorescent prfobes for saccharides signaling using the boronic acid group.
Tetrahedron Lett. 2002 Apr 1;43(14):2615-2618. doi: 10.1016/s0040-4039(02)00312-x. Epub 2002 Mar 6.
2
Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry.
Chem Rev. 2016 Dec 28;116(24):15235-15283. doi: 10.1021/acs.chemrev.6b00543. Epub 2016 Dec 16.
3
Chromones: A Promising Ring System for New Anti-inflammatory Drugs.
ChemMedChem. 2016 Oct 19;11(20):2252-2260. doi: 10.1002/cmdc.201600359. Epub 2016 Sep 15.
4
Sulfonamide chalcones: Synthesis and in vitro exploration for therapeutic potential against Brugia malayi.
Eur J Med Chem. 2016 Nov 29;124:262-269. doi: 10.1016/j.ejmech.2016.08.042. Epub 2016 Aug 21.
5
Design, synthesis and antiproliferative activity studies of novel dithiocarbamate-chalcone derivates.
Bioorg Med Chem Lett. 2016 Aug 15;26(16):3918-22. doi: 10.1016/j.bmcl.2016.07.012. Epub 2016 Jul 5.
6
Redox signaling: An evolution from free radicals to aging.
Free Radic Biol Med. 2016 Aug;97:398-407. doi: 10.1016/j.freeradbiomed.2016.07.003. Epub 2016 Jul 5.
7
Exercise, Nrf2 and Antioxidant Signaling in Cardiac Aging.
Front Physiol. 2016 Jun 17;7:241. doi: 10.3389/fphys.2016.00241. eCollection 2016.
8
Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity.
Eur J Med Chem. 2016 Oct 21;122:232-246. doi: 10.1016/j.ejmech.2016.06.035. Epub 2016 Jun 22.
9
Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
J Ethnopharmacol. 2016 Sep 15;191:350-359. doi: 10.1016/j.jep.2016.06.039. Epub 2016 Jun 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验